Merck to co-lead global cancer big data alliance
12 September, 2017Merck is collaborating with independent not-for-profit Project Data Sphere to jointly lead the Global Oncology Big Data Alliance (GOBDA).
Caucasian ovarian cancer patients should stick to standard dosing, study finds
05 September, 2017European women with ovarian cancer should stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to the results of the phase III ICON8 trial.
Stem cell therapy for Parkinson's disease
01 September, 2017 by Adam FloranceSufferers of Parkinson's disease may soon be enjoying improved movement thanks to a team of researchers from Kyoto University, Japan, and some crab-eating macaques.
Australian specialists may hold key to ovarian cancer treatment
31 August, 2017Three Australian cancer treatment centres are involved in a drug trial that could see the next major advancement in ovarian cancer therapy.
Garvan launches Genomic Cancer Medicine Program for rare cancers
31 August, 2017In Australia, around 52,000 people will be diagnosed with rare and less common (RLC) cancers in 2017, according to estimates by Cancer in Australia 2017.
Avita Medical hires Erin Liberto as CCO
31 August, 2017Medical device company Avita Medical has named Erin Liberto as the company's chief commercial officer.
Stemina prepares to launch autism diagnostic product
24 August, 2017As it gears up for the launch of its autism diagnostic test panel, US metabolomics company Stemina Biomarker Discovery has announced the appointment of Dr Heiner Dreismann to its board of directors.
Sniffing out Alzheimer's early
24 August, 2017 by Adam FloranceCanadian researchers have found that a simple smell test may help in diagnosing those at risk of developing Alzheimer's disease.
'Stiffer' blood vessels may increase risk of heart attack
22 August, 2017Research led by Macquarie University has found that blood vessel 'stiffness', or distensibility, is an important determinant of blood flow, and may play a role in influencing the fate of Australians living with coronary heart disease.
Inadequate T-cell development linked to autoimmune diseases
18 August, 2017 by Adam FloranceResearchers have determined that mutations in the gene encoding a particular enzyme may help in the development of better treatments for a wide range of autoimmune diseases.
Tumour blood supply stopped in its tracks by dextran-catechin
10 August, 2017 by Adam FloranceAn international study, led by researchers from the Children's Cancer Institute and University of New South Wales, has uncovered a new way of dealing with neuroblastoma, a form of cancer that typically affects infants as young as one or two years of age.
LBT to trial diabetic foot ulcer prototype
09 August, 2017LBT Innovations, an Australian-listed medical technology company, has signed an agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services to use LBT's WoundVue prototype device in a clinical trial.
Targeting the Achilles' heel of breast cancer
04 August, 2017 by Adam FloranceResearchers have found that by combining traditional treatments with a new class of anticancer agents they can target the 'Achilles' heel' of HER2-positive breast cancers, in the first significant improvement in this area in over 30 years.
Blocking the enzyme that helps tumours grow
03 August, 2017Targeting healthy cells that have been hijacked by cancer cells could help treat many different types of the disease, according to scientists from the University of Southampton.
HaemaLogiX signs research agreement with local health institutions
27 July, 2017HaemaLogiX, an Australian immuno-oncology company, has signed an agreement with local health and research institutions for commercialisation rights to an immuno-oncology agent designed to specifically target malignant cancer cells present in the bone marrow of multiple myeloma patients.
